National Research: Q3 Earnings Snapshot
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $27
NRC Health (NRC) Q3 2026 Earnings Call Transcript
National Research Q3 Earnings Call Highlights
NRC Health Announces Third Quarter 2026 Results
National Research Q3 Adj. EPS $0.21, Inline, Sales $38.399M Beat $35.800M Estimate
NRC Health Launches nQuire Pro, Extending the Reach of Patient-Experience Teams
NRC Health Appoints CEO Trent Green As Interim Principal Financial Officer
New NRC Health Research Reveals What Sets High-Performing Health Systems Apart: Turning Patient Feedback Into Action
NRC Health's Dividend Analysis
The Governance Institute Blue Ribbon Committee Reframes Hospital and Health System Board Assessment with Four Considerations for Stronger Governance
KLAS First Look: NRC Health Rounding Earns 91.6 Overall Performance Score
NRC Health Announces 2026 Award Winners Recognizing Excellence Across Healthcare
On Aug 7, Shane Harrison, CFO of NRC Health, Tendered Resignation From The Co.; Resignation Effective As August 28, 2026
Record Backlog Powers NRC Health’s (NRC) Upward Potential
NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth
New NRC Health Research Reveals What Drives Patient Loyalty Beyond Access
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26
NRC Health (NRC) Q2 2026 Earnings Call Highlights: Strong TRCV Growth Amid Market Uncertainty
NRC Health (NRC) Q2 2026 Earnings Call Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.